Systemic use of tumor necrosis factor alpha as an anticancer agent

Tumor necrosis factor-α (TNF-α) has been discussed as a potential anticancer agent for many years, however initial enthusiasm about its clinical use as a systemic agent was curbed due to significant toxicities and lack of efficacy. Combination of TNF-α with chemotherapy in the setting of hyperthermi...

Descripción completa

Detalles Bibliográficos
Autores principales: Roberts, Nicholas J., Zhou, Shibin, Diaz, Luis A., Holdhoff, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2011
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248159/
https://www.ncbi.nlm.nih.gov/pubmed/22036896

Ejemplares similares

Ejemplares similares